Aftertrade Broking Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 13(4), 14(3) and 15(2) of Securities and Exchange ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
A group of five acquirers (Arvind Karsandas Bhanushali and family members) along with one person acting in concert (PAC) have made a mandatory open offer to public shareholders of Aspira Pathlab & Diagnostics Ltd to buy up to 26,76,180 equity shares (26% of voting capital) at Rs.55 per share, totaling a maximum payout of about Rs.14.72 crore. The offer is triggered under SEBI Takeover Regulations due to an underlying acquisition that will take the acquirers' combined holding from 23.82% to 49.82% post-completion. The acquirers are existing promoters and their relatives, indicating a consolidation of promoter family control rather than a third-party takeover. Tendering period is scheduled from November 24, 2025 to December 5, 2025.
Public shareholders can tender their shares at Rs.55 each during the tendering window. This is essentially a family-driven consolidation with no change planned in the existing diagnostics business, and no competing offer has been announced.